Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENXA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,591.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,591.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, awarded on November 5, 2025, represents one of multiple orders issued to the vendor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense pharmaceutical supply acquisition strategy. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) under this program with a $499.999 billion ceiling value extending through December 31, 2036, positioning the company as a critical regional prime vendor contractor for military healthcare operations globally. No set-aside designation was applied to this award, indicating the contractor competed in unrestricted procurement.
This delivery order authorizes the supply of pharmaceutical products and medical consumables to support Department of Defense medical facilities. DMS Pharmaceutical Group's comprehensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables spanning multiple therapeutic categories. The contractor's recent substantial federal contracting activity, including numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, demonstrates consistent performance capability in fulfilling the diverse and specialized pharmaceutical requirements of the military medical system. Performance is scheduled for completion by November 6, 2025, with execution at the contractor's Park Ridge, Illinois location.
Quick answers
Who was awarded contract SPE2DU26FENXA?
SPE2DU26FENXA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DU26FENXA worth?
The government has obligated $11,591 on SPE2DU26FENXA.
Is contract SPE2DU26FENXA an order under another contract?
Yes. SPE2DU26FENXA is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXA competed?
The extent of competition for SPE2DU26FENXA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award